Literature DB >> 28935989

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2.

S Bartels1, M Faisal1, G Büsche1, J Schlue1, H Kreipe1, U Lehmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28935989     DOI： 10.1038/leu.2017.298

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Analysis of Mutational Hotspots in Routinely Processed Bone Marrow Trephines by Pyrosequencing®.

Authors:  Stephan Bartels; Ulrich Lehmann
Journal:  Methods Mol Biol       Date:  2015

2.  SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis.

Authors:  Ulrich Lehmann; Stephan Bartels; Britta Hasemeier; Robert Geffers; Jerome Schlue; Guntram Büsche; Kais Hussein; Hans Kreipe
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

3.  Study on the Clinical Significance of JAK2V617F Allele Burden in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.

Authors:  Peisong Chen; Juan Ouyang; Jianming Liang; Xuegao Yu; Bin Huang
Journal:  Clin Lab       Date:  2016-08-01       Impact factor: 1.138

4.  Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.

Authors:  Damien Luque Paz; Aurélie Chauveau; Françoise Boyer; Caroline Buors; Laura Samaison; Laurane Cottin; Valérie Seegers; Claude Férec; Cédric Le Maréchal; Paul Gueguen; Eric Lippert; Jean-Christophe Ianotto; Valérie Ugo
Journal:  Genes Chromosomes Cancer       Date:  2017-02-01       Impact factor: 5.006

5.  Mutations and prognosis in primary myelofibrosis.

Authors:  A M Vannucchi; T L Lasho; P Guglielmelli; F Biamonte; A Pardanani; A Pereira; C Finke; J Score; N Gangat; C Mannarelli; R P Ketterling; G Rotunno; R A Knudson; M C Susini; R R Laborde; A Spolverini; A Pancrazzi; L Pieri; R Manfredini; E Tagliafico; R Zini; A Jones; K Zoi; A Reiter; A Duncombe; D Pietra; E Rumi; F Cervantes; G Barosi; M Cazzola; N C P Cross; A Tefferi
Journal:  Leukemia       Date:  2013-04-26       Impact factor: 11.528

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

Authors:  Pontus Lundberg; Axel Karow; Ronny Nienhold; Renate Looser; Hui Hao-Shen; Ina Nissen; Sabine Girsberger; Thomas Lehmann; Jakob Passweg; Martin Stern; Christian Beisel; Robert Kralovics; Radek C Skoda
Journal:  Blood       Date:  2014-01-29       Impact factor: 22.113

8.  Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2017-01       Impact factor: 10.047

Review 9.  Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.

Authors:  S Cerquozzi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-11-13       Impact factor: 11.037

Review 10.  Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.

Authors:  Stephan Bartels; Elisa Schipper; Britta Hasemeier; Hans Kreipe; Ulrich Lehmann
Journal:  Oncotarget       Date:  2016-05-24
View more
  3 in total

Review 1.  The Role of Megakaryocytes in Myelofibrosis.

Authors:  Johanna Melo-Cardenas; Anna Rita Migliaccio; John D Crispino
Journal:  Hematol Oncol Clin North Am       Date:  2021-01-11       Impact factor: 3.722

Review 2.  Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation.

Authors:  Florian Perner; Caroline Perner; Thomas Ernst; Florian H Heidel
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

Review 3.  Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses.

Authors:  Vibe Skov
Journal:  Cancers (Basel)       Date:  2020-08-06       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.